NCT07545460 2026-04-22A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerSichuan Baili Pharmaceutical Co., Ltd.Phase 3 Not yet recruiting404 enrolled